Výsledky vyhledávání - "Rocio D. Marchese"

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naïve adults ≥50 years of age

Autor: Charles P. Andrews, Luwy Musey, Richard E. Rupp, Chitrananda Abeygunawardana, Steven D. Folkerth, Richard D. McFetridge, Rocio D. Marchese, David Greenberg, Jon E. Stek, Susan Ermlich, Jonathan Hartzel

Publikováno v: Vaccine. 36:6875-6882

Background Pneumococcal disease remains a public health priority in adults. Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) containing 13 serotypes included in 13-valent pneumococcal conjugate vaccine (PCV13) plus 2 addi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd0c8732f4552c121867e81dbe8a2f9c
https://doi.org/10.1016/j.vaccine.2018.03.012

Zobrazit plný text záznamu

Safety, Tolerability and Immunogenicity of 15-valent Pneumococcal Conjugate Vaccine in Toddlers Previously Vaccinated With 7-valent Pneumococcal Conjugate Vaccine

Autor: Michael J. Dallas, Steven Shapiro, Rocio D. Marchese, Ajoke Sobanjo-ter Meulen, Timo Vesikari, Luwy Musey, Patricia A. Hoover, Wendy J. Watson, Edgardo A. Malacaman, Richard D. McFetridge, Jonathan Hartzel, Jon E. Stek

Publikováno v: Pediatric Infectious Disease Journal. 34:186-194

Widespread use of 7-valent pneumococcal conjugate vaccine (PCV7) in children has led to significant reduction in pneumococcal disease in children and adults. However, diseases caused by serotypes not included in PCV7 have increased. A 15-valent pneum

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e3bfb2753e0e4f6b07202056e381674
https://doi.org/10.1097/inf.0000000000000516

Zobrazit plný text záznamu

Major depressive disorder and immunity to varicella-zoster virus in the elderly

Autor: Anne Lucko, Carmen Carrillo, Myron J. Levin, Michael R. Irwin, Michael N. Oxman, Patricia T. McCook, Jim Clair, Ivan S. F. Chan, Michael J. Caulfield, Jeffrey G. Smith, Danielle J. Beck, Nancy Lang, Gary R. Johnson, Heather M. Williams, Adriana Weinberg, Rocio D. Marchese, Richard G. Olmstead

Publikováno v: Brain, Behavior, and Immunity. 25:759-766

Major depressive disorder has been associated with activation of inflammatory processes as well as with reductions in innate, adaptive and non-specific immune responses. The objective of this study was to evaluate the association between major depres

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57cfc76be36f4a47590fa66ba53d4d1c
https://doi.org/10.1016/j.bbi.2011.02.001

Zobrazit plný text záznamu

Safety and Antibody Response, Including Antibody Persistence for 5 Years, after Primary Vaccination or Revaccination with Pneumococcal Polysaccharide Vaccine in Middle‐Aged and Older Adults

Autor: Rocio D. Marchese, Carla Painter, Michael D. Blum, Frances B. Alvarez, Bonnie Bushnell, Richard D. McFetridge, Jeffrey L. Silber, Susan B. Manoff, Charlie Liss, Daniel M. Musher

Publikováno v: The Journal of Infectious Diseases. 201:516-524

Background This study assessed antibody levels for 5 years after primary vaccination or revaccination with 23-valent pneumococcal polysaccharide vaccine (PN23). Methods Subjects were enrolled into 4 study groups by age (50-64 or > or = 65 years) and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f58fc4c9202e19ace7dc45f80b89880a
https://doi.org/10.1086/649839

Zobrazit plný text záznamu

Revaccination with a 23‐Valent Pneumococcal Polysaccharide Vaccine Induces Elevated and Persistent Functional Antibody Responses in Adults Aged ⩾65 Years

Autor: Rocio D. Marchese, Michael J. Caulfield, Jeffrey L. Silber, George M. Carlone, Susan B. Manoff, Gowrisankar Rajam, Sandra Romero-Steiner, Cynthia G. Whitney, Charles Liss, Nina E. Glass, John Boslego

Publikováno v: The Journal of Infectious Diseases. 201:525-533

BACKGROUND: Older adults are at high risk of developing invasive pneumococcal disease, but the optimal timing and number of vaccine doses needed to prevent disease among this group are unknown. We compared revaccination with 23-valent pneumococcal po

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb9de51f7bb887c79c3b13f62bdbd4c5
https://doi.org/10.1086/651131

Zobrazit plný text záznamu

Complexities of Clinical Assay Development and Optimization Prior to First-in-Man Immunization Trials – A Description of Immunogenicity Assay Development for the Testing of Samples from a Phase 1 Alzheimer's Vaccine Trial

Autor: Leonard J. Rubinstein, James M. Reynolds, Olivia Hammond, Daniel Sikkema, Rocio D. Marchese

Publikováno v: Journal of Immunoassay and Immunochemistry. 29:332-347

Immunogenicity is often a critical clinical endpoint in the assessment of vaccines prior to the submission of data to regulatory agencies. As a result, the assays used to measure immunogenicity must be highly characterized, well-controlled, and stati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9734e0d64b15217e9d852b0d8e5beee2
https://doi.org/10.1080/15321810802329518

Zobrazit plný text záznamu

Plný text ve formátu HTML

Safety, tolerability, and immunogenicity of 15-valent pneumococcal conjugate vaccine in healthy adults

Autor: Jonathan Hartzel, Michael J. Dallas, Luwy Musey, Rocio D. Marchese, Ajoke Sobanjo-ter Meulen, Steven D. Folkerth, John A. Hoekstra, Patricia A. Hoover, Jon E. Stek, Richard D. McFetridge, Wendy J. Watson, Donna M. Zacholski

Publikováno v: Vaccine. 33(24)

Background Pneumococcal disease remains an important health priority despite successful implementation of pneumococcal conjugate vaccines (PCVs) in infant immunization programs, mainly due to the emergence of diseases caused by serotypes not included

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f88a24cf8571bc51aa6498dfb4605b1
https://pubmed.ncbi.nlm.nih.gov/25913828

Zobrazit plný text záznamu

Comparison of a New Multiplex Binding Assay versus the Enzyme-Linked Immunosorbent Assay for Measurement of Serotype-Specific Pneumococcal Capsular Polysaccharide IgG ▿

Autor: Joseph M. Antonello, Lindsey Ashton, Rocio D. Marchese, Yuhua Zhang, David Goldblatt

The measurement of serotype-specific anti-capsular polysaccharide antibodies remains the mainstay of pneumococcal (Pn) vaccine evaluation. New methods that allow the simultaneous measurement of antibodies to several antigens in small volumes of serum

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::538904322632084df2c82ad7ed56c538
https://europepmc.org/articles/PMC3187042/

Zobrazit plný text záznamu

Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adults

Autor: Rocio D. Marchese, Patricia A. Hoover, Daniel M. Musher, Susan B. Manoff, Jennifer Raab, Monica L Walker, Richard D. McFetridge, Adriana M. Rueda, Charles Liss

Publikováno v: Human vaccines. 7(9)

In a study of older adults, first and second doses of 23-valent pneumococcal polysaccharide vaccine (PN23) induced IgG increases for all 8 vaccine serotypes tested. Participants (N=143, mean age 76 years) were re-enrolled to study antibody levels aft

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad3582534f17651c12a0b3d640a0b99e
https://pubmed.ncbi.nlm.nih.gov/21860256

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání